| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermodysplasia Verruciformis | 7 | 2023 | 13 | 1.770 |
Why?
|
| Ichthyosis | 11 | 2022 | 31 | 1.720 |
Why?
|
| Skin Diseases | 5 | 2022 | 140 | 1.690 |
Why?
|
| Collagen Type VII | 5 | 2018 | 29 | 1.390 |
Why?
|
| Homozygote | 16 | 2024 | 547 | 1.390 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2024 | 931 | 1.360 |
Why?
|
| Epidermolysis Bullosa | 9 | 2022 | 29 | 1.360 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 3 | 2018 | 46 | 1.160 |
Why?
|
| Pseudoxanthoma Elasticum | 4 | 2022 | 4 | 1.130 |
Why?
|
| Papillomavirus Infections | 6 | 2026 | 392 | 1.120 |
Why?
|
| Consanguinity | 14 | 2024 | 118 | 1.100 |
Why?
|
| Mutation | 31 | 2024 | 6144 | 1.030 |
Why?
|
| Genetic Testing | 4 | 2024 | 1094 | 0.990 |
Why?
|
| Skin | 13 | 2026 | 549 | 0.980 |
Why?
|
| Genetic Heterogeneity | 4 | 2022 | 134 | 0.880 |
Why?
|
| Epigenomics | 1 | 2025 | 181 | 0.860 |
Why?
|
| Hypotrichosis | 2 | 2019 | 8 | 0.760 |
Why?
|
| Pedigree | 22 | 2025 | 1703 | 0.750 |
Why?
|
| Machine Learning | 1 | 2025 | 362 | 0.720 |
Why?
|
| Skin Diseases, Vesiculobullous | 2 | 2018 | 3 | 0.710 |
Why?
|
| Mutation, Missense | 8 | 2021 | 925 | 0.690 |
Why?
|
| Patched-1 Receptor | 1 | 2020 | 38 | 0.650 |
Why?
|
| Sequence Deletion | 2 | 2019 | 513 | 0.650 |
Why?
|
| Ichthyosis, Lamellar | 4 | 2022 | 7 | 0.630 |
Why?
|
| Whole Genome Sequencing | 3 | 2023 | 355 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2025 | 3397 | 0.600 |
Why?
|
| DNA Methylation | 1 | 2025 | 1082 | 0.580 |
Why?
|
| Cadherins | 1 | 2019 | 176 | 0.570 |
Why?
|
| Warts | 3 | 2023 | 17 | 0.570 |
Why?
|
| Transcriptome | 2 | 2023 | 1144 | 0.570 |
Why?
|
| Macular Degeneration | 1 | 2019 | 91 | 0.570 |
Why?
|
| Mosaicism | 1 | 2020 | 241 | 0.570 |
Why?
|
| Epidermolysis Bullosa Simplex | 3 | 2022 | 6 | 0.460 |
Why?
|
| Humans | 67 | 2026 | 130931 | 0.450 |
Why?
|
| Membrane Proteins | 6 | 2023 | 1611 | 0.440 |
Why?
|
| Iran | 10 | 2024 | 96 | 0.410 |
Why?
|
| Genes, Recessive | 6 | 2021 | 201 | 0.410 |
Why?
|
| Keratinocytes | 3 | 2025 | 74 | 0.400 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 896 | 0.380 |
Why?
|
| Epidermis | 3 | 2022 | 64 | 0.370 |
Why?
|
| DNA Mutational Analysis | 6 | 2019 | 801 | 0.370 |
Why?
|
| Eczema | 2 | 2022 | 35 | 0.370 |
Why?
|
| Loss of Function Mutation | 2 | 2025 | 160 | 0.350 |
Why?
|
| Quantitative Trait Loci | 2 | 2025 | 307 | 0.340 |
Why?
|
| RNA Splicing | 2 | 2023 | 234 | 0.330 |
Why?
|
| Papillomaviridae | 5 | 2022 | 181 | 0.310 |
Why?
|
| T-Lymphocytes | 3 | 2026 | 1768 | 0.300 |
Why?
|
| Cohort Studies | 7 | 2024 | 5096 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2025 | 2849 | 0.300 |
Why?
|
| Male | 36 | 2026 | 64823 | 0.300 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 608 | 0.300 |
Why?
|
| Cutis Laxa | 2 | 2020 | 10 | 0.300 |
Why?
|
| Lipase | 3 | 2019 | 88 | 0.300 |
Why?
|
| DNA Copy Number Variations | 2 | 2025 | 1022 | 0.290 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 2 | 2019 | 3 | 0.290 |
Why?
|
| Dyslipidemias | 2 | 2024 | 246 | 0.290 |
Why?
|
| Female | 33 | 2026 | 70755 | 0.290 |
Why?
|
| Genome-Wide Association Study | 4 | 2025 | 1834 | 0.280 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 199 | 0.280 |
Why?
|
| Blister | 2 | 2018 | 21 | 0.270 |
Why?
|
| Computational Biology | 2 | 2025 | 870 | 0.270 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2025 | 97 | 0.270 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 330 | 0.260 |
Why?
|
| Phenotype | 13 | 2025 | 4493 | 0.250 |
Why?
|
| Immunologic Surveillance | 1 | 2026 | 14 | 0.240 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2026 | 29 | 0.240 |
Why?
|
| Child | 17 | 2025 | 26098 | 0.240 |
Why?
|
| Genetic Association Studies | 6 | 2019 | 834 | 0.230 |
Why?
|
| Inheritance Patterns | 3 | 2021 | 129 | 0.230 |
Why?
|
| Basement Membrane | 3 | 2022 | 40 | 0.230 |
Why?
|
| Adolescent | 13 | 2025 | 20814 | 0.230 |
Why?
|
| Vitamin E Deficiency | 1 | 2024 | 2 | 0.230 |
Why?
|
| Neoplasms | 3 | 2025 | 2955 | 0.220 |
Why?
|
| GATA2 Transcription Factor | 1 | 2025 | 46 | 0.220 |
Why?
|
| GTPase-Activating Proteins | 1 | 2025 | 87 | 0.220 |
Why?
|
| Vitamin E | 1 | 2024 | 63 | 0.220 |
Why?
|
| Alleles | 5 | 2020 | 1705 | 0.220 |
Why?
|
| Child, Preschool | 12 | 2025 | 14945 | 0.220 |
Why?
|
| Connective Tissue | 2 | 2021 | 28 | 0.220 |
Why?
|
| Dermatitis, Atopic | 1 | 2025 | 54 | 0.210 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 19 | 0.210 |
Why?
|
| Adult | 16 | 2026 | 31541 | 0.200 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 112 | 0.200 |
Why?
|
| Incidental Findings | 1 | 2024 | 125 | 0.200 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 244 | 0.200 |
Why?
|
| Genomics | 4 | 2024 | 1617 | 0.200 |
Why?
|
| Genetics, Medical | 1 | 2024 | 119 | 0.200 |
Why?
|
| Oxidoreductases | 2 | 2021 | 102 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 266 | 0.200 |
Why?
|
| DNA | 2 | 2019 | 1444 | 0.200 |
Why?
|
| Ataxia | 1 | 2024 | 171 | 0.200 |
Why?
|
| Heterozygote | 3 | 2020 | 726 | 0.200 |
Why?
|
| Ichthyosis Vulgaris | 1 | 2022 | 2 | 0.190 |
Why?
|
| Alphapapillomavirus | 1 | 2023 | 48 | 0.190 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2022 | 27 | 0.190 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2022 | 8 | 0.190 |
Why?
|
| Muscular Dystrophies | 1 | 2022 | 52 | 0.190 |
Why?
|
| Vitamin D | 1 | 2024 | 189 | 0.180 |
Why?
|
| Pyrin | 1 | 2021 | 3 | 0.180 |
Why?
|
| Familial Mediterranean Fever | 1 | 2021 | 4 | 0.180 |
Why?
|
| Tetraspanin 24 | 2 | 2021 | 2 | 0.180 |
Why?
|
| Dermatitis | 1 | 2021 | 28 | 0.180 |
Why?
|
| Homeodomain Proteins | 1 | 2025 | 566 | 0.180 |
Why?
|
| Integrin alpha3 | 1 | 2021 | 2 | 0.180 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 391 | 0.170 |
Why?
|
| Vascular Calcification | 1 | 2022 | 70 | 0.170 |
Why?
|
| CD28 Antigens | 1 | 2021 | 75 | 0.170 |
Why?
|
| Leukocyte Disorders | 2 | 2020 | 2 | 0.170 |
Why?
|
| Claudin-1 | 2 | 2020 | 19 | 0.170 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 198 | 0.170 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2020 | 19 | 0.170 |
Why?
|
| Mycoses | 1 | 2021 | 112 | 0.170 |
Why?
|
| Alopecia | 2 | 2020 | 42 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 747 | 0.160 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2020 | 11 | 0.160 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2020 | 75 | 0.160 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1067 | 0.160 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 55 | 0.160 |
Why?
|
| Neutropenia | 1 | 2021 | 205 | 0.150 |
Why?
|
| Genes, Modifier | 1 | 2019 | 15 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2024 | 1021 | 0.150 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2018 | 6 | 0.150 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2018 | 7 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2018 | 660 | 0.150 |
Why?
|
| DNA, Recombinant | 1 | 2018 | 71 | 0.150 |
Why?
|
| Chromosome Fragility | 1 | 2018 | 13 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 339 | 0.150 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2018 | 2 | 0.150 |
Why?
|
| Betapapillomavirus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2018 | 9 | 0.150 |
Why?
|
| Disease Progression | 1 | 2025 | 2191 | 0.150 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2018 | 4 | 0.140 |
Why?
|
| Connexins | 1 | 2018 | 63 | 0.140 |
Why?
|
| Phenylketonurias | 1 | 2018 | 15 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 632 | 0.140 |
Why?
|
| Receptors, Peptide | 1 | 2018 | 57 | 0.140 |
Why?
|
| Peru | 1 | 2018 | 56 | 0.140 |
Why?
|
| Keratosis | 1 | 2018 | 17 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 224 | 0.140 |
Why?
|
| Photosensitivity Disorders | 1 | 2017 | 11 | 0.140 |
Why?
|
| Autoantigens | 1 | 2018 | 104 | 0.140 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2017 | 2 | 0.140 |
Why?
|
| Syndrome | 4 | 2023 | 1154 | 0.140 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2022 | 70 | 0.130 |
Why?
|
| Mexico | 1 | 2018 | 197 | 0.130 |
Why?
|
| Periodontal Diseases | 1 | 2017 | 33 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 302 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1559 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 194 | 0.130 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 232 | 0.130 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 201 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 155 | 0.130 |
Why?
|
| Point Mutation | 1 | 2018 | 338 | 0.130 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1821 | 0.130 |
Why?
|
| Keratin-14 | 1 | 2016 | 10 | 0.130 |
Why?
|
| Keratin-5 | 1 | 2016 | 9 | 0.120 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 311 | 0.120 |
Why?
|
| Infant | 5 | 2024 | 13210 | 0.120 |
Why?
|
| Stroke | 1 | 2024 | 1041 | 0.120 |
Why?
|
| Genome, Human | 2 | 2021 | 1331 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2018 | 409 | 0.120 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1071 | 0.110 |
Why?
|
| Hospitalization | 1 | 2023 | 1925 | 0.110 |
Why?
|
| Phospholipases | 3 | 2019 | 9 | 0.110 |
Why?
|
| Cell Movement | 3 | 2026 | 874 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 1278 | 0.100 |
Why?
|
| Acyltransferases | 3 | 2019 | 61 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 400 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2025 | 102 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2017 | 483 | 0.100 |
Why?
|
| Genotype | 4 | 2019 | 2651 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2076 | 0.090 |
Why?
|
| Siblings | 2 | 2020 | 204 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2020 | 307 | 0.070 |
Why?
|
| RNA Splice Sites | 2 | 2019 | 92 | 0.070 |
Why?
|
| Young Adult | 5 | 2020 | 10040 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1741 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 419 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2019 | 749 | 0.060 |
Why?
|
| Comorbidity | 2 | 2023 | 1587 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2026 | 44 | 0.060 |
Why?
|
| Base Sequence | 2 | 2021 | 2781 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 3067 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1614 | 0.060 |
Why?
|
| Founder Effect | 1 | 2024 | 34 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2025 | 130 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2575 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2024 | 117 | 0.050 |
Why?
|
| Prognosis | 3 | 2018 | 4930 | 0.050 |
Why?
|
| Animals | 5 | 2025 | 34278 | 0.050 |
Why?
|
| Retinoids | 1 | 2022 | 29 | 0.050 |
Why?
|
| Plectin | 1 | 2022 | 6 | 0.050 |
Why?
|
| Zebrafish | 1 | 2025 | 422 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 306 | 0.050 |
Why?
|
| Introns | 1 | 2023 | 287 | 0.050 |
Why?
|
| Pyrophosphatases | 1 | 2022 | 22 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2024 | 393 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2025 | 649 | 0.050 |
Why?
|
| Papilloma | 1 | 2021 | 22 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2024 | 686 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 2021 | 40 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2021 | 84 | 0.040 |
Why?
|
| Water Loss, Insensible | 1 | 2021 | 3 | 0.040 |
Why?
|
| Skin Abnormalities | 1 | 2021 | 35 | 0.040 |
Why?
|
| gamma Catenin | 1 | 2020 | 1 | 0.040 |
Why?
|
| Triglycerides | 1 | 2024 | 607 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2021 | 110 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 76 | 0.040 |
Why?
|
| Exons | 1 | 2023 | 767 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4738 | 0.040 |
Why?
|
| Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 164 | 0.040 |
Why?
|
| Kallikreins | 1 | 2020 | 26 | 0.040 |
Why?
|
| Ichthyosiform Erythroderma, Congenital | 1 | 2020 | 5 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 2020 | 16 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2021 | 452 | 0.040 |
Why?
|
| Mucositis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2020 | 30 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2021 | 201 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 379 | 0.040 |
Why?
|
| England | 1 | 2019 | 58 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 332 | 0.040 |
Why?
|
| Acitretin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Keratolytic Agents | 1 | 2019 | 6 | 0.040 |
Why?
|
| Connexin 26 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 195 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 281 | 0.040 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2018 | 16 | 0.040 |
Why?
|
| Exanthema | 1 | 2020 | 74 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2019 | 83 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 28735 | 0.040 |
Why?
|
| Xenopus | 1 | 2018 | 103 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 802 | 0.040 |
Why?
|
| Collagen Type XVIII | 1 | 2018 | 2 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 101 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 191 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 496 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2018 | 62 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 216 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 97 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 140 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 218 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2017 | 75 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2018 | 185 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 311 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2560 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 227 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 674 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1500 | 0.030 |
Why?
|
| Oocytes | 1 | 2018 | 288 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 32 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2016 | 78 | 0.030 |
Why?
|
| Geography | 1 | 2016 | 119 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 530 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 294 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 249 | 0.030 |
Why?
|
| Family | 1 | 2019 | 588 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 1040 | 0.030 |
Why?
|
| Haplotypes | 1 | 2016 | 543 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 373 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 18410 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2287 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Prevalence | 1 | 2019 | 2681 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2095 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3850 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 21134 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10901 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3675 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4681 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7558 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6862 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8542 | 0.020 |
Why?
|